BioFocus Launches Academic Engagement Initiative
News May 01, 2013
BioFocus has announced that it has launched its Academic Engagement initiative (AEi). Based on years of experience working with academic and non-profit institutions, the primary aim of the initiative is to identify the best new therapeutic strategy ideas from academic groups, and to provide an effective and user-friendly mechanism to progress these ideas towards high quality chemical matter.
As part of the interaction model, BioFocus will contribute to grant writing and will provide ideas on funding mechanisms, but will not seek to retain any IP related to the projects; this will remain with the idea-originating institution.
“BioFocus has been assisting researchers to translate their discoveries into small molecule space for many years and will continue to enable these exciting early-stage projects,” said Professor Julie Frearson, BioFocus’ Senior Director Scientific Alliances and Translational Programs.
Professor Frearson continued, “BioFocus is also well positioned to take key projects to preclinical proof of concept and beyond towards candidate nomination.”
Research Team Discovers Compound that Stops Cancer From SpreadingNews
Using a mouse model, OHSU physician-scientists lead effort to hone a drug that inhibits cancer cells from spreading to other areas in the body.READ MORE
PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery ProgramsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.READ MORE